EU-funded researchers have demonstrated huge potential for treating aggressive brain cancer using actively personalised immunotherapy in a first first-stage clinical trial to test the vaccine’s safety.Powered by WPeMatico
EU-funded researchers have demonstrated huge potential for treating aggressive brain cancer using actively personalised immunotherapy in a first first-stage clinical trial to test the vaccine’s safety.